Kris Clark
About Kris Clark
Kris Clark serves as the Director of Kinase Biology at Exscientia, where he has worked since 2021. He is recognized for mentoring teams and fostering collaborative networks, with a strong focus on developing pharmacodynamic biomarkers for clinical candidates.
Work at Exscientia
Kris Clark has served as the Director of Kinase Biology at Exscientia since 2021. In this role, he focuses on developing pharmacodynamic biomarkers to enhance the progression of clinical candidates. His leadership includes mentoring high-performing individuals and teams, fostering a collaborative environment both internally and externally. His expertise in kinase biology contributes to Exscientia's mission of advancing drug discovery through innovative approaches.
Previous Experience at Sygnature Discovery
Before joining Exscientia, Kris Clark worked at Sygnature Discovery for a total of five years, holding positions as Principal Scientist from 2019 to 2021 and Senior Scientist from 2016 to 2019. During his tenure, he contributed to various projects in drug discovery, leveraging his extensive knowledge in chemical biology and pharmacology to drive scientific advancements.
Educational Background
Kris Clark has a robust educational background in medical sciences and molecular biology. He earned his PhD from Radboud University Nijmegen in the Netherlands, where he studied from 2002 to 2007. Prior to this, he obtained an M Phil from JCSMR at the Australian National University and an M Sc in Molecular Biology from Université de Montréal. He also holds a BSc in Chemistry/Biochemistry from Concordia University. This diverse academic foundation supports his expertise in kinase biology and drug discovery.
Research Contributions and Specializations
Kris Clark specializes in translating knowledge from chemical biology, genetics, and proteomics into effective screening cascades for drug discovery. He has played a significant role in the development of two candidate molecules in the immuno-oncology field, with one currently undergoing phase I clinical trials. His work emphasizes the importance of pharmacodynamic biomarkers in the clinical development process.
Career Development and Mentorship
Kris Clark is recognized for his commitment to mentoring and developing high-performing teams. His ability to build collaborative networks has been instrumental in his career, facilitating connections between academia, biotech, and pharmaceutical industries. His passion for nurturing the next generation of therapeutics reflects his dedication to advancing scientific research and innovation.